| Literature DB >> 21326540 |
Adam Ryan Geronemus1, Constantino S Peña.
Abstract
Available and improved options for the treatment of femoral-popliteal disease have increased over the last decade. Even though most patients suffering from claudication due to femoral-popliteal disease are treated with aggressive medical and noninvasive methods, patients with limb-threatening disease and severely lifestyle-limiting symptoms are treated with invasive treatments, which include endovascular treatment options. Unfortunately, the unique forces involved in this vascular segment have challenged the long-term patency and clinical effectiveness of these treatments. The purpose of this brief review is to discuss treatment strategies and options for patients with femoral-popliteal disease. Included in this discussion will be the review of data from recent published studies and late-breaking trials as it pertains to certain treatment strategies.Entities:
Keywords: Superficial femoral artery; angioplasty; claudication; critical limb ischemia; stent
Year: 2009 PMID: 21326540 PMCID: PMC3036472 DOI: 10.1055/s-0029-1242203
Source DB: PubMed Journal: Semin Intervent Radiol ISSN: 0739-9529 Impact factor: 1.513